✦ LIBER ✦

98 EXTENDED (2 YEARS) TREATMENT WITH PEGINTERFERON ALFA-2A [40KD] IMPROVES SUSTAINED RESPONSE RATES IN GENOTYPE D PATIENTS WITH HBEAG NEGATIVE CHRONIC HEPATITIS B

✍ Scribed by P. Lampertico; M. Vigano; G. Di Costanzo; E. Sagnelli; M. Fasano; V. Di Marco; S. Boninsegna; P. Farci; S. Fargion; T. Giuberti; C. Iannacone; B. Massetto; P. Fedeli; M. Colombo

Book ID: 117378186
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 52 KB
Volume: 52
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(10)60100-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

743 The majority of patients with HBeAg-

743 The majority of patients with HBeAg-negative chronic hepatitis B treated with peginterferon alpha-2a (40KD) [PEGASYS®] sustain responses 2 years post-treatment

✍ P. Marcellin; E. Bonino; G.K.K. Lau; P. Farci; C. Yurdaydin; T. Piratvisuth; R. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 115 KB

P.112 Response is sustained two years po

P.112 Response is sustained two years post-treatment in the majority of patients with HBeAg-negative chronic hepatitis B treated with peginterferon alpha-2a (40KD) [PEGASYS®]

✍ P. Marcellin; F. Bonino; G.K.K. Lau; P. Farci; C. Yurdaydin; T. Piratvisuth; R. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 281 KB

Treatment with peginterferon alfa-2a (40

Treatment with peginterferon alfa-2a (40KD) (PEGASYS®) results in improved rates of response compared to conventional interferon in patients with HBEAG positive chronic hepatitis B harboring HBV genotypes B or ‘difficult-to-treat’ genotype C

✍ W.G.E. Cooksley; M.-Y. Lai; T. Piratvisuth; Y.-J. Wang; V. Mahachai; Y.-C. Chao; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 135 KB

103 VIROLOGICAL AND BIOCHEMICAL RESPONSE

103 VIROLOGICAL AND BIOCHEMICAL RESPONSE IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B TREATED WITH PEGINTERFERON ALFA-2A (40KD) WITH OR WITHOUT LAMIVUDINE: RESULTS OF 4-YEAR FOLLOW-UP

✍ P. Marcellin; T. Piratvisuth; M. Brunetto; F. Bonino; G.K.K. Lau; P. Farci; C. Y 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Predicting sustained virological respons

Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin

✍ Peter Ferenci; Michael W. Fried; Mitchell L. Shiffman; Coleman I. Smith; George 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Predicting sustained virological respons

Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin

✍ Eric Snoeck; Janet R. Wade; Frank Duff; Matthew Lamb; Karin Jorga 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 739 KB